A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor

Neuron

Volumn 40, Issue 4, 2003, Pages 685-694

  Pollitt, Sonia K ^a   Pallos, Judit ^b   Shao, Jieya ^d   Desai, Urvee A ^d   Ma, Aye Aye K ^d   Thompson, Leslie Michels ^b,c   Marsh, J Lawrence ^b   Diamond, Marc I ^d  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POLYGLUTAMINE; PROTEIN P160; RHO KINASE;

ARTICLE; BIOASSAY; DEGENERATIVE DISEASE; DROSOPHILA; ENERGY TRANSFER; FLUORESCENCE RESONANCE ENERGY TRANSFER ASSAY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; REDUCTION; SCREENING TEST; SIGNAL TRANSDUCTION; TECHNIQUE;

EID: 0242657586     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00697-4     Document Type: Article

References (40)

1. Abel A., Walcott J., Woods J., Duda J., Merry D. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Genet. 10:2001;107-116.
2. Berthelier V., Hamilton J.B., Chen S., Wetzel R. A microtiter plate assay for polyglutamine aggregate extension. Anal. Biochem. 295:2001;227-236.
3. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell. 113:2003;457-468.
4. Cowan K.J., Diamond M.I., Welch W.J. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum. Mol. Genet. 12:2003;1377-1391.
5. Diamond M.I., Robinson M.R., Yamamoto K.R. Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 97:2000;657-661.
6. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
7. Ellerby L.M., Hackam A.S., Propp S.S., Ellerby H.M., Rabizadeh S., Cashman N.R., Trifiro M.A., Pinsky L., Wellington C.L., Salvesen G.S., et al. Kennedy's disease. caspase cleavage of the androgen receptor is a crucial event in cytotoxicity J. Neurochem. 72:1999;185-195.
8. Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine- induced disease in SCA1 transgenic mice. Neuron. 38:2003;375-387.
9. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature. 420:2002;629-635.
10. Garcia-Mata R., Bebok Z., Sorscher E.J., Sztul E.S. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146:1999;1239-1254.
11. Georgalis Y., Starikov E.B., Hollenbach B., Lurz R., Scherzinger E., Saenger W., Lehrach H., Wanker E.E. Huntingtin aggregation monitored by dynamic light scattering. Proc. Natl. Acad. Sci. USA. 95:1998;6118-6121.
12. Hirose M., Ishizaki T., Watanabe N., Uehata M., Kranenburg O., Moolenaar W.H., Matsumura F., Maekawa M., Bito H., Narumiya S. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141:1998;1625-1636.
13. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 23:1999;181-192.
14. Humbert S., Bryson E.A., Cordelieres F.P., Connors N.C., Datta S.R., Finkbeiner S., Greenberg M.E., Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell. 2:2002;831-837.
15. Huntington Collaborative A novel (The Huntington's Disease Collaborative Research Group) gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
16. Ishizaki T., Naito M., Fujisawa K., Maekawa M., Watanabe N., Saito Y., Narumiya S. p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett. 404:1997;118-124.
17. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57:2000;976-983.
18. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes. a cellular response to misfolded proteins J. Cell Biol. 143:1998;1883-1898.
19. Kennedy W.R., Alter M., Sung J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 18:1968;671-680.
20. Kim S., Nollen E.A., Kitagawa K., Bindokas V.P., Morimoto R.I. Polyglutamine protein aggregates are dynamic. Nat. Cell Biol. 4:2002;826-831.
21. Lamarche N., Tapon N., Stowers L., Burbelo P.D., Aspenstrom P., Bridges T., Chant J., Hall A. Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell. 87:1996;519-529.
22. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352:1991;77-79.
23. Li M., Miwa S., Kobayashi Y., Merry D.E., Yamamoto M., Tanaka F., Doyu M., Hashizume Y., Fischbeck K.H., Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol. 44:1998;249-254.
24. Meriin A.B., Mabuchi K., Gabai V.L., Yaglom J.A., Kazantsev A., Sherman M.Y. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J. Cell Biol. 153:2001;851-864.
25. Merry D.E., Kobayashi Y., Bailey C.K., Taye A.A., Fischbeck K.H. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7:1998;693-701.
26. Muchowski P.J., Ning K., D'Souza-Schorey C., Fields S. Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. Proc. Natl. Acad. Sci. USA. 99:2002;727-732.
27. Narumiya S., Ishizaki T., Uehata M. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol. 325:2000;273-284.
28. Paulson H.L., Perez M.K., Trottier Y., Trojanowski J.Q., Subramony S.H., Das S.S., Vig P., Mandel J.L., Fischbeck K.H., Pittman R.N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 19:1997;333-344.
29. Peters P.J., Ning K., Palacios F., Boshans R.L., Kazantsev A., Thompson L.M., Woodman B., Bates G.P., D'Souza-Schorey C. Arfaptin 2 regulates the aggregation of mutant huntingtin protein. Nat. Cell Biol. 4:2002;240-245.
30. Root D.E., Flaherty S.P., Kelley B.P., Stockwell B.R. Biological mechanism profiling using an annotated compound library. Chem. Biol. 10:2003;881-892.
31. Schaufele F., Wang X., Liu X., Day R.N. Conformation of CCAAT/enhancer-binding protein alpha dimers varies with intranuclear location in living cells. J. Biol. Chem. 278:2003;10578-10587.
32. Sekar R.B., Periasamy A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160:2003;629-633.
33. Snyder E.Y., Deitcher D.L., Walsh C., Arnold-Aldea S., Hartwieg E.A., Cepko C.L. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell. 68:1992;33-51.
34. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greenwald M., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 413:2001;739-743.
35. Taylor J.P., Tanaka F., Robitschek J., Sandoval C.M., Taye A., Markovic-Plese S., Fischbeck K.H. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12:2003;749-757.
36. Wanker E.E., Scherzinger E., Heiser V., Sittler A., Eickhoff H., Lehrach H. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309:1999;375-386.
37. Weatherman R.V., Chang C.Y., Clegg N.J., Carroll D.C., Day R.N., Baxter J.D., McDonnell D.P., Scanlan T.S., Schaufele F. Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer. Mol. Endocrinol. 16:2002;487-496.
38. Welch W.J., Diamond M.I. Glucocorticoid modulation of androgen receptor nuclear aggregation and cellular toxicity is associated with distinct forms of soluble expanded polyglutamine protein. Hum. Mol. Genet. 10:2001;3063-3074.
39. Wyttenbach A., Carmichael J., Swartz J., Furlong R.A., Narain Y., Rankin J., Rubinsztein D.C. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc. Natl. Acad. Sci. USA. 97:2000;2898-2903.
40. Zhang J.H., Chung T.D., Oldenburg K.R. Confirmation of primary active substances from high throughput screening of chemical and biological populations. a statistical approach and practical considerations J. Comb. Chem. 2:2000;258-265.